These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 31654265
1. A computational study of the molecular basis of antibiotic resistance in a DXR mutant. Krebs FS, Esque J, Stote RH. J Comput Aided Mol Des; 2019 Oct; 33(10):927-940. PubMed ID: 31654265 [Abstract] [Full Text] [Related]
7. The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation. Mac Sweeney A, Lange R, Fernandes RP, Schulz H, Dale GE, Douangamath A, Proteau PJ, Oefner C. J Mol Biol; 2005 Jan 07; 345(1):115-27. PubMed ID: 15567415 [Abstract] [Full Text] [Related]
9. Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake. Brown AC, Parish T. BMC Microbiol; 2008 May 20; 8():78. PubMed ID: 18489786 [Abstract] [Full Text] [Related]
13. [Evaluation of in vitro antibacterial activity of fosmidomycin and its derivatives]. Shtannikov AV, Sergeeva EE, Biketov SF, Ostrovskiĭ DN. Antibiot Khimioter; 2007 May 20; 52(7-8):3-9. PubMed ID: 18986018 [Abstract] [Full Text] [Related]
14. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme. Singh N, Chevé G, Avery MA, McCurdy CR. Curr Pharm Des; 2007 May 20; 13(11):1161-77. PubMed ID: 17430177 [Abstract] [Full Text] [Related]
15. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling. Zhang B, Watts KM, Hodge D, Kemp LM, Hunstad DA, Hicks LM, Odom AR. Biochemistry; 2011 May 03; 50(17):3570-7. PubMed ID: 21438569 [Abstract] [Full Text] [Related]
16. Alteration of the flexible loop in 1-deoxy-D-xylulose-5-phosphate reductoisomerase boosts enthalpy-driven inhibition by fosmidomycin. Kholodar SA, Tombline G, Liu J, Tan Z, Allen CL, Gulick AM, Murkin AS. Biochemistry; 2014 Jun 03; 53(21):3423-31. PubMed ID: 24825256 [Abstract] [Full Text] [Related]
17. Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly. Slade JA, Brockett M, Singh R, Liechti GW, Maurelli AT. PLoS Pathog; 2019 Oct 03; 15(10):e1008078. PubMed ID: 31622442 [Abstract] [Full Text] [Related]
18. α,α-Difluorophosphonohydroxamic Acid Derivatives among the Best Antibacterial Fosmidomycin Analogues. Dreneau A, Krebs FS, Munier M, Ngov C, Tritsch D, Lièvremont D, Rohmer M, Grosdemange-Billiard C. Molecules; 2021 Aug 23; 26(16):. PubMed ID: 34443699 [Abstract] [Full Text] [Related]
19. Crystal structure of 1-deoxy-d-xylulose 5-phosphate reductoisomerase from the hyperthermophile Thermotoga maritima for insights into the coordination of conformational changes and an inhibitor binding. Takenoya M, Ohtaki A, Noguchi K, Endo K, Sasaki Y, Ohsawa K, Yajima S, Yohda M. J Struct Biol; 2010 Jun 23; 170(3):532-9. PubMed ID: 20353826 [Abstract] [Full Text] [Related]
20. A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase. Mercklé L, de Andrés-Gómez A, Dick B, Cox RJ, Godfrey CR. Chembiochem; 2005 Oct 23; 6(10):1866-74. PubMed ID: 16116659 [Abstract] [Full Text] [Related] Page: [Next] [New Search]